Hedge Funds Are Betting On Cryolife Inc (CRY)

Page 1 of 2

Cryolife Inc (NYSE:CRY) has seen an increase in enthusiasm from smart money in recent months.

In the 21st century investor’s toolkit, there are dozens of indicators investors can use to watch stocks. Two of the most underrated are hedge fund and insider trading interest. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the best investment managers can beat the S&P 500 by a superb amount (see just how much).


Just as beneficial, positive insider trading sentiment is a second way to parse down the investments you’re interested in. As the old adage goes: there are a number of stimuli for an insider to cut shares of his or her company, but only one, very obvious reason why they would behave bullishly. Many academic studies have demonstrated the market-beating potential of this strategy if shareholders understand what to do (learn more here).

Keeping this in mind, let’s take a glance at the key action regarding Cryolife Inc (NYSE:CRY).

What have hedge funds been doing with Cryolife Inc (NYSE:CRY)?

In preparation for this quarter, a total of 8 of the hedge funds we track held long positions in this stock, a change of 14% from one quarter earlier. With hedge funds’ capital changing hands, there exists a few notable hedge fund managers who were boosting their holdings considerably.

When looking at the hedgies we track, Royce & Associates, managed by Chuck Royce, holds the most valuable position in Cryolife Inc (NYSE:CRY). Royce & Associates has a $6.7 million position in the stock, comprising less than 0.1%% of its 13F portfolio. Sitting at the No. 2 spot is Jim Simons of Renaissance Technologies, with a $1.6 million position; less than 0.1%% of its 13F portfolio is allocated to the stock. Remaining peers with similar optimism include D. E. Shaw’s D E Shaw, Peter Algert and Kevin Coldiron’s Algert Coldiron Investors and Israel Englander’s Millennium Management.

As aggregate interest increased, some big names have been driving this bullishness. Bryn Mawr Capital, managed by Ken Gray and Steve Walsh, initiated the most outsized position in Cryolife Inc (NYSE:CRY). Bryn Mawr Capital had 0.1 million invested in the company at the end of the quarter.

What have insiders been doing with Cryolife Inc (NYSE:CRY)?

Insider trading activity, especially when it’s bullish, is at its handiest when the company we’re looking at has experienced transactions within the past half-year. Over the last half-year time period, Cryolife Inc (NYSE:CRY) has seen zero unique insiders purchasing, and 1 insider sales (see the details of insider trades here).

Let’s go over hedge fund and insider activity in other stocks similar to Cryolife Inc (NYSE:CRY). These stocks are RTI Biologics Inc. (NASDAQ:RTIX), Zeltiq Aesthetics Inc (NASDAQ:ZLTQ), Cutera, Inc. (NASDAQ:CUTR), Solta Medical Inc (NASDAQ:SLTM), and Hansen Medical, Inc. (NASDAQ:HNSN). This group of stocks belong to the medical appliances & equipment industry and their market caps resemble CRY’s market cap.

Page 1 of 2